Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis. Swiss Med Wkly [Internet]. 2024 Jul. 25 [cited 2025 Oct. 23];154(7):3695. Available from: https://www.smw.ch/index.php/smw/article/view/3695